Identification of protein kinase inhibitors to reprogram breast cancer cells

Keyphrases

• Breast Cancer Cells 100%
• Protein Kinase Inhibitors 100%
• Transcription Factor 40%
• Pluripotent Stem Cells 20%
• Adipocyte 20%
• Clinical Trials 20%
• Mammalian Target of Rapamycin (mTOR) 20%
• Breast Cancer 20%
• Cancer Treatment 20%
• Progenitor Cells 20%
• Tumorigenicity 20%
• Local Recurrence 20%
• Breast Cancer Treatment 20%
• Kinase Inhibitor 20%
• Anticancer Drugs 20%
• Transcriptional Analysis 20%
• Target of Rapamycin Kinase 20%
• Adipogenic 20%
• Reprogramming Methods 20%
• In Vivo Tumorigenesis 20%
• Cancer Cell Reprogramming 20%
• Kinase Inhibitor Design 20%
• Reprogramming Strategies 20%
• Cancer Cell Treatment 20%
• Rho-associated Protein Kinase 20%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Protein Kinases 100%
• Reprogramming 50%
• Transcription Factors 33%
• Stem Cell 16%
• Adipocyte 16%
• Clinical Trial 16%
• Carcinogenesis 16%
• Progenitor Cell 16%
• Revertant 16%
• Protein Kinase A 16%
• Mechanistic Target of Rapamycin 16%
• Cell Reprogramming Technique 16%
• Rho-Associated Protein Kinase 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Protein Kinase Inhibitor 100%
• Malignant Neoplasm 28%
• Transcription Factors 28%
• Clinical Trial 14%
• Carcinogenesis 14%
• Recurrent Disease 14%
• Mammalian Target of Rapamycin Inhibitor 14%
• Protein Kinases 14%
• Phosphotransferase Inhibitor 14%
• Cyclic AMP Dependent Protein Kinase 14%
• Anticarcinogen 14%
• Carcinogenicity 14%